TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 3.255
-0.050 (-1.51%)
Sep 18, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 1.25 billion as of September 18, 2026. Its market cap has decreased by -80.65% in one year.
Market Cap
1.25B
Enterprise Value
1.19B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.26
ChartMarket Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 1.25B, a decrease of -75.35%. That is a compound annual growth rate of -49.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.25B | -74.87% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 1.61B |
| SinoMab BioScience | 1.56B |
| Shandong Boan Biotechnology | 1.52B |
| Beijing Biostar Pharmaceuticals | 1.49B |
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| CANbridge Pharmaceuticals | 1.20B |